Study Indicates Use of CNS Response rEEG-Guidance for Treatment Resistant Depression to Be Superior to American Psychiatric Association Guidelines Most Commonly Used by Payers

COSTA MESA, CA--(Marketwire - October 31, 2008) - CNS Response, Inc. (OTCBB: CNSO) reported the results of a study by the Center for Health Economics, Epidemiology, and Science Policy at United BioSource Corporation, a global pharmacoeconomic research firm and one of the most experienced firms providing evidence-based review of innovative healthcare technologies.